TELA Bio’s Growth Hampered by COVID; OviTex Adoption Will Increase

TELA Bio’s Growth Hampered by COVID; OviTex Adoption Will Increase

Can TELA Bio navigate the COVID pandemic and challenge the current standard of care to generate meaningful and sustained growth?

Report Date :
08/30/2021
Topic :
Tela Bio
Source Silos :
1) Surgeons using OviTex 2) Surgeons not using OviTex 3) Medical device sales channel 4) Industry specialists 5) Secondary sources
Sector :
Health Care
Companies :
ABBV, BDX, IART, JNJ, MDT, TELA
Industry :
Health Care Equipment & Supplies

TELA Bio’s Growth Hampered by COVID; OviTex Adoption Will Increase PDF